The intracellular parasite Trypanosoma cruzi, the etiological agent of Chag
as disease, sheds a developmentally regulated surface trans-sialidase, whic
h is involved in key aspects of parasite-host cell interactions. Although i
t shares a common active site architecture with bacterial neuraminidases, t
he T.cruzi enzyme behaves as a highly efficient sialyltransferase. Here we
report the crystal structure of the closely related Trypanosoma rangeli sia
lidase and its complex with inhibitor. The enzyme folds into two distinct d
omains: a catalytic beta-propeller fold tightly associated with a lectin-li
ke domain. Comparison with the modeled structure of T.cruzi trans-sialidase
and mutagenesis experiments allowed the identification of amino acid subst
itutions within the active site cleft that modulate sialyltransferase activ
ity and suggest the presence of a distinct binding site for the acceptor ca
rbohydrate, The structures of the Trypanosoma enzymes illustrate how a glyc
osidase scaffold can achieve efficient glycosyltransferase activity and pro
vide a framework for structure-based drug design.